当前位置:首页 - 行情中心 - 欧林生物(688319) - 财务分析

欧林生物

(688319)

  

流通市值:156.89亿  总市值:156.89亿
流通股本:4.05亿   总股本:4.05亿

欧林生物(688319)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.27亿元,每股收益0.07元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益93117.74万元,未分配利润-5043.84万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产201991.17万元,负债108873.43万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入157,803,808.92704,160,325.32506,920,470.94305,849,689.82
营业总成本136,476,818.31659,117,720.56440,264,661.39267,455,854.27
其他经营收益
营业利润32,392,401.9530,857,171.4855,605,554.7314,691,495.92
利润总额32,422,385.4231,893,209.8955,750,565.2614,682,785.21
净利润27,197,714.6821,898,737.1947,148,308.4413,229,790.42
每股收益
其他综合收益----
综合收益总额27,197,714.6821,898,737.1947,148,308.4413,229,790.42
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计998,755,242.25996,333,512.94964,223,718.56908,203,566.45
非流动资产:
非流动资产合计1,021,156,465.741,026,736,270.08980,745,921.32928,030,524.41
资产总计2,019,911,707.992,023,069,783.021,944,969,639.881,836,234,090.86
流动负债:
流动负债合计737,061,113.92737,073,224.41632,389,342.18562,784,387.37
非流动负债:
非流动负债合计351,673,180.47382,016,859.69344,241,955.21339,029,879.02
负债合计1,088,734,294.391,119,090,084.1976,631,297.39901,814,266.39
所有者权益(或股东权益):
归属于母公司股东权益合计930,868,035.65903,678,718.78959,846,714.83925,563,838.32
股东权益合计931,177,413.6903,979,698.92968,338,342.49934,419,824.47
负债和股东权益合计2,019,911,707.992,023,069,783.021,944,969,639.881,836,234,090.86
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计136,960,725.75670,816,894.15440,054,821.11249,294,781.17
经营活动现金流出小计162,385,314.26565,323,116.79407,009,586.17269,033,461.69
经营活动产生的现金流量净额-25,424,588.51105,493,777.3633,045,234.94-19,738,680.52
投资活动产生的现金流量:
投资活动现金流入小计135,125,136.99200,525,572.5795,287,167.135,178,242.44
投资活动现金流出小计157,909,127.36323,020,455.58192,769,448.6974,368,914.08
投资活动产生的现金流量净额-22,783,990.37-122,494,883.01-97,482,281.59-39,190,671.64
筹资活动产生的现金流量:
筹资活动现金流入小计20,000,000176,100,000125,000,00095,000,000
筹资活动现金流出小计26,103,399.86151,699,743.83115,053,727.5575,909,320.79
筹资活动产生的现金流量净额-6,103,399.8624,400,256.179,946,272.4519,090,679.21
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-54,311,978.747,399,150.52-54,490,774.2-39,838,672.95
期末现金及现金等价物余额170,864,002.79225,175,981.53163,286,056.81177,938,158.06
补充资料:
现金及现金等价物的净增加额-7,399,150.52--39,838,672.95
最新报告期:2026-04-03
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信建投汤然,刘若飞,贺菊颖0.080.120.192026-04-03
TOP↑